BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 27, 2005
View Archived Issues
A phase I study reports antitumor activity for irofulven plus docetaxel
Read More
Peru-15 cholera vaccine found safe and immunogenic in adults and children
Read More
PTCA shows therapeutic potential for NASH
Read More
Promising results reported with a novel vaccine against Gram-positive bacteria
Read More
New data confirm the benefits of TH-070 in symptomatic BPH
Read More
Callisto reports plans for upcoming phase I/II ALL trial with annamycin
Read More
Callisto to evaluate atiprimod for treatment of myelodysplastic syndrome
Read More
NOX-B11: A novel ghrelin antagonist for obesity
Read More
Update on paricalcitol in the treatment of SHPT
Read More
DTwPHibHBV vaccine reported safe and immunogenic in humans
Read More
Phase II data on the effects of 4-OHT in cyclic mastalgia
Read More
Tanaproget shows efficacy as a novel contraceptive in healthy women
Read More
A drospirenone/ethinylestradiol combination shows promise in PMDD
Read More
Affitech enters licensing agreement for cancer-specific antibodies
Read More
NICE recommends use of Caelyx as second-line or subsequent treatment of advanced ovarian cancer
Read More
Par and Optimer enter development and collaboration agreement for PAR-101
Read More
Parent Project Muscular Dystrophy and Asklepios collaboration supports DMD gene therapy
Read More
Vitamin D3 analogue shows promise in a murine model of colitis-associated colon cancer
Read More
VistaGen Therapeutics receives NIH grant for preclinical studies of AV-101 for epilepsy
Read More
Inhaled insulin feasible and acceptable in patients with diabetes
Read More
Muraglitazar effective in randomized, double-blind trials in type 2 diabetes
Read More
Silodosin improves BPH symptoms in phase III trial
Read More
Recurrences unaffected by fenretinide in non-muscle invasive bladder cancer
Read More
Amitriptyline effective but limited by anticholinergic effects in interstitial cystitis
Read More
Novavax reports promising preclinical results with MNP technology
Read More
Patient enrollment in pivotal trial of Conor's CoStar drug-eluding stent commences
Read More
Norelin induces antitumor effects in patients with HDPC
Read More
Novel therapeutic agents for gastrointestinal disorders revealed in patents
Read More
Recent patents disclose novel analgesic agents
Read More
New therapeutics for cardiovascular diseases reported
Read More
GlaxoSmithKline submits BLA for Fluarix flu vaccine
Read More
Daiichi Suntory Pharma reports change in company name
Read More
Xenical receives positive opinion in E.U. for weight loss in adolescents
Read More